Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2003
04/17/2003WO2003031419A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
04/17/2003WO2003031064A1 Method and apparatus for transporting biological samples
04/17/2003WO2003031063A2 Device for holding a substance library carrier
04/17/2003WO2003031054A2 Arrays having clustered arrangements and methods of making and using them
04/17/2003WO2003030938A1 Immunotherapeutics for cancer
04/17/2003WO2003030924A1 Identification of specific modulators of bone formation
04/17/2003WO2003030922A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis
04/17/2003WO2003030836A2 Neuronal regeneration
04/17/2003WO2003030833A2 Angiopoietin-2 specific binding agents
04/17/2003WO2003030831A2 Treatment of prostate cancer by inhibitors of atp synthase
04/17/2003WO2003030817A2 Antibody complexes and methods for immunolabeling
04/17/2003WO2003030719A2 Methods and kits for use in selecting approaches to treating cancer
04/17/2003WO2003030624A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
04/17/2003WO2003030622A2 Detection and characterization of pyschoactives using analysis of network level physiological responses in a neuronal sample
04/17/2003WO2003030621A2 Low-cost on-line and in-line spectral sensors based on solid-state source and detector combinations
04/17/2003WO2003030616A2 21132, a human g-protein coupled receptor family member and uses therefor
04/17/2003WO2003030612A2 Methods for modulating activity of the fxr nuclear receptor
04/17/2003WO2003021254A3 Method for testing a beverage for illicit substances
04/17/2003WO2003016903A3 Device and method for determining an analyte
04/17/2003WO2003013585A8 Mifaxin agonists and antagonists for use in the treatment of metabolic
04/17/2003WO2003008949A3 Method for identifying potential differences in the gene pool of cells
04/17/2003WO2003003063A3 Fiber-optic sensor array
04/17/2003WO2003000271A3 System and method for the large scale labeling of compounds with radiohalogens
04/17/2003WO2002094985A3 Beta-secretase substrates and uses thereof
04/17/2003WO2002094863A3 INTERFERON-α INDUCED GENE
04/17/2003WO2002090937A3 Method and device for removing waste water samples
04/17/2003WO2002085943A3 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
04/17/2003WO2002084295A3 Method for assaying flowing media for microbial toxins
04/17/2003WO2002083727A3 Nucleic acid sequences of hyperplasies and tumors of the thyroid
04/17/2003WO2002082045A3 Thin film sensor array for the detection of gases and a method of making
04/17/2003WO2002081735A3 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives
04/17/2003WO2002077188A3 Human serine/threonine kinase
04/17/2003WO2002072863A3 Methods for large scale protein matching
04/17/2003WO2002072636A3 Crystals of whole antibodies and fragments thereof and methods for making and using them
04/17/2003WO2002072622A3 Vaccine antigens against infection by chlamydia trachomatis
04/17/2003WO2002070743A3 Identification and use of inhibitors of hair growth
04/17/2003WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof
04/17/2003WO2002064823A3 Method for detecting and/or quantifying an analyte
04/17/2003WO2002064615A3 Monoclonal antibodies to human immunodeficiency virus and uses thereof
04/17/2003WO2002063270A3 The use of mesoscale self-assembly and recognition to effect delivery of sensing reagent for arrayed sensors
04/17/2003WO2002061428A3 Method of disrupting interactions between biotin and biotin-binding compounds
04/17/2003WO2002060662A3 System for and method of performing evaluation techniques on a log or round timber
04/17/2003WO2002057416A3 Improved biochip
04/17/2003WO2002055667A3 Identification of an advanced sleep phase syndrome gene in humans
04/17/2003WO2002052276A3 Protein s functional assay
04/17/2003WO2002051237A9 Helicobacter proteins, nucleic acids and uses thereof
04/17/2003WO2002050284A3 Oxidoreductases
04/17/2003WO2002048708A3 Assay for anti-viral agent
04/17/2003WO2002048315A3 Monoclonal antibody probe for detection of adhesins associated with mature endospores of pasteuria spp.
04/17/2003WO2002042766A9 A system and method for investigating the effect of chemical and other factors on cell movement
04/17/2003WO2002037109A3 Detection of binding species with colloidal and non-colloidal structures
04/17/2003WO2002032960A3 Methods of selecting compounds for modulation of bladder function
04/17/2003WO2002029036A3 Lipid metabolism enzymes
04/17/2003WO2002027327A3 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome
04/17/2003WO2002021134A3 Methods of diagnosing breast cancer and screening for modulators
04/17/2003WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3)
04/17/2003WO2002018575A3 Genes expressed in the cell cycle
04/17/2003WO2002018445A3 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
04/17/2003WO2002010402A3 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides
04/17/2003WO2002006831A8 Method for establishing the effect of a substance on living cells
04/17/2003WO2002004674A3 Transposon mediated multiplex sequencing
04/17/2003WO2002004511A3 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
04/17/2003WO2002002798A3 Methods and compositions for the modulation of chorismate synthase and chorismate mutase expression or activity in plants
04/17/2003WO2002000721A3 Cytokine receptor zcytor17
04/17/2003WO2001098366A3 Enterokinase cleavage sequences and their use
04/17/2003WO2001085210A3 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
04/17/2003WO2001072773A3 Genes isolated from dendritic cells, gene products and methods employing the same
04/17/2003WO2001069251A3 Method for diagnosing immunologic food sensitivity
04/17/2003WO2001046687A3 System and method for automated matched ion polynucleotide chromatography
04/17/2003US20030074700 Expression of human milk proteins in transgenic plants
04/17/2003US20030074363 Method and system for providing a polymorphism database
04/17/2003US20030074142 Coincidence detection programmed media and system
04/17/2003US20030074141 Meta-models for predicting blood brain barrier penetration based on simple physicochemical descriptors
04/17/2003US20030073866 Labeling nucleic acids with fluorescent complex of cyanine dye and carbodiimide compound
04/17/2003US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents
04/17/2003US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
04/17/2003US20030073821 Antibody for use in human therapeutics and diagnostics
04/17/2003US20030073819 PGC-1, a novel brown fat PPARgamma coactivator
04/17/2003US20030073818 D-1 like dopamine receptor activity modifying protein
04/17/2003US20030073815 Treatment of brain disorders; obtain adrenic acid or mimetic, administer to human, monitor adjusment in brain disorder
04/17/2003US20030073813 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030073811 Generation of preferential proteins; provide nucleotide sequences, amplify, incubate nucleotide sequences with nuclease, clone sequences into expression vector, express coded proteins, recover proteins
04/17/2003US20030073810 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders
04/17/2003US20030073809 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders
04/17/2003US20030073696 Oxazolidinone photoaffinity probes
04/17/2003US20030073654 Stabilized transient gene expression
04/17/2003US20030073635 Diagnosis and treatment of disorders of iron metabolism
04/17/2003US20030073632 Controlling gene expression; apoptosis therapy
04/17/2003US20030073624 Anticancer agents; isolated nucleic acids; genetic engineering
04/17/2003US20030073610 Prevention protein misfolding; central nervous system disorders; Alzheimer's, Parkinson's, Huntington's disease therapy
04/17/2003US20030073250 Method and apparatus for solid state molecular analysis
04/17/2003US20030073249 Allergen test chip for use in monitoring allergic response of animal to antigens
04/17/2003US20030073245 Apparatus for use in the accurate detection and measurement of preferential targets in sample
04/17/2003US20030073244 Method and apparatus for diagnosing hemostasis
04/17/2003US20030073243 Method for quantitative determination of glycated hemoglobin
04/17/2003US20030073241 System, method, and apparatus for disease susceptibility testing
04/17/2003US20030073240 Method for evaluating concentration of metallic impurities in silicon wafer
04/17/2003US20030073228 Peelable and resealable devices for arraying materials
04/17/2003US20030073218 Enzyme inhibitor for us in the treatment and prevention of tumors
04/17/2003US20030073216 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
1 ... 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 ... 3937